Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New insights on how FMDV replicates
The team are now looking at how mutations in polyproteins could be used for producing attenuated vaccines.
Tiny protein could be the key to better vaccines  

Fresh insights on the replication processes of foot-and-mouth disease virus (FMDV) could pave the way for more effective vaccines, scientists say.

New findings published in PLOS Pathogens describe a tiny protein called 3B3, which is known to play a major role in the replication of FMDV. However, it also helps to increase the efficiency with which it can pack information into the genome, according to the Pirbright Institute and the University of Leeds.

FMD has a small amount of genetic material, so it has found ways to multiply its functions. During replication, the virus creates a string of proteins called polyproteins which are then cut up into their individual proteins. The research team discovered that 3B3 is key to directing the processing of the P3 polyprotein into its constituent parts.

Such methods are also used by other members of the picornavirus family, such as poliovirus, as well as non-picornaviruses.

Scientists say that systems such as these could be exploited to develop attenuated vaccines. The team are now looking at how mutations in polyproteins could be used for producing such vaccines.

Become a member or log in to add this story to your CPD history

BEVA gives RVNs right to vote

News Story 1
 The British Equine Veterinary Association (BEVA) is to allow its registered veterinary nurse (RVN) members the right to vote.

RVN members will now be able to take part in key decision-making processes and stand for BEVA council.

Marie Rippingale, chair of BEVA's Nurse Committee, said: "I am very proud to be a part of BEVA.

"This change will help to empower nurses to speak up and contribute, but more importantly, it will give them an opportunity to collaborate with other members of the equine veterinary profession to bring about change that is positive for all." 

Click here for more...
News Shorts
Bluetongue vaccines comparison table produced for vets

The Ruminant Health and Welfare Group has produced a comparison table on the vaccines available in the UK for bluetongue virus serotype 3.

The three vaccines, which have been permitted for use by the secretary of state for environment, food and rural affairs, claim to reduce symptoms rather than prevent animals from catching the disease.

The table looks at a range of different factors for each vaccine, including their use in sheep and cattle, their use during pregnancy, adverse events, and storage requirements.

The comparisons have been compiled by Flock Health in collaboration with the British Veterinary Association, the British Cattle Veterinary Association, the Sheep Veterinary Society, the British Deer Veterinary Association, the British Camelid Association, and the Goat Vet Society.

The comparison table, and further information on the bluetongue vaccines, can be accessed here.